万孚生物：彭仲雄减持29700股完毕

Group 1 - The core point of the article is that Wanfang Bio announced the completion of a stock reduction plan by its director and senior management personnel, Peng Zhongxiong, who sold a total of 29,700 shares, accounting for 0.0064% of the company's total share capital [1] Group 2 - The stock reduction was executed through a centralized bidding method [1] - The reduction plan has been fully implemented [1]